Curis (CRIS) EBT (QoQ) (2010 - 2026)
Curis (CRIS) EBT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | Curis | 3.35 Mn | -2.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -160.66% |
| Dec 31, 2025 | 350.43% |
| Sep 30, 2025 | 10.05% |
| Jun 30, 2025 | 19.06% |
| Mar 31, 2025 | -4.85% |
| Dec 31, 2024 | 4.86% |
| Sep 30, 2024 | 12.85% |
| Jun 30, 2024 | 4.30% |
| Mar 31, 2024 | -12.17% |
| Dec 31, 2023 | 11.72% |
| Sep 30, 2023 | -0.81% |
| Jun 30, 2023 | -5.71% |
| Mar 31, 2023 | -16.48% |
| Dec 31, 2022 | 21.90% |
| Sep 30, 2022 | 17.97% |
| Jun 30, 2022 | 1.97% |
| Mar 31, 2022 | -19.97% |
| Dec 31, 2021 | -24.08% |
| Sep 30, 2021 | 5.73% |
| Jun 30, 2021 | -16.01% |